Matthew Lang - Net Worth and Insider Trading
Matthew Lang Net Worth
The estimated net worth of Matthew Lang is at least $10 Million dollars as of 2024-12-15. Matthew Lang is the General Counsel & Corp. Secy. of Myovant Sciences Ltd and owns about 354,303 shares of Myovant Sciences Ltd (MYOV) stock worth over $10 Million. Details can be seen in Matthew Lang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Lang has not made any transactions after 2023-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Lang
Matthew Lang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Lang owns 2 companies in total, including Myovant Sciences Ltd (MYOV) , and Lyell Immunopharma Inc (LYEL) .
Click here to see the complete history of Matthew Lang’s form 4 insider trades.
Insider Ownership Summary of Matthew Lang
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MYOV | Myovant Sciences Ltd | 2023-01-18 | General Counsel & Corp. Secy. |
LYEL | Lyell Immunopharma Inc | 2023-07-01 | Chief Business Officer |
Matthew Lang Latest Holdings Summary
Matthew Lang currently owns a total of 1 stock. Matthew Lang owns 354,303 shares of Myovant Sciences Ltd (MYOV) as of January 18, 2023, with a value of $10 Million.
Latest Holdings of Matthew Lang
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOV | Myovant Sciences Ltd | 2023-01-18 | 354,303 | 26.98 | 9,559,095 |
Holding Weightings of Matthew Lang
Matthew Lang Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Lang has made a total of 20 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Myovant Sciences Ltd is the sale of 1,272 shares on January 18, 2023, which brought Matthew Lang around $34,204.
Insider Trading History of Matthew Lang
- 1
Matthew Lang Trading Performance
Matthew Lang Ownership Network
Ownership Network List of Matthew Lang
Ownership Network Relation of Matthew Lang
Matthew Lang Owned Company Details
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Matthew Lang is the General Counsel & Corp. Secy. of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and Chief Medical Officer Ferreira Juan Camilo Arjona .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
Matthew Lang Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Lang. You might contact Matthew Lang via mailing address: C/o Myovant Sciences Inc., 2000 Sierra Point Parkway, 9th Floor, Brisbane Ca 94005.